Shots:

• Roche received a CE mark for its SARS-CoV-2 Ag self-test nasal at home setting for COVID 19. The test will be available in countries accepting the CE mark
• The early version of the test is available in the EU under special approval pathways since Feb- 2021. The test can be performed by individuals using nasal swap & can deliver results in 15mins
• The test demonstrates 91.1% relative sensitivity and 99.6 % overall relative specificity from the combined study. Additionally- Roche offers NAVIFY Pass digital solution that enables individuals to share their test results and vaccine status through a unique QR code

Ref: Roche | Image: Roche